September 3, 2020 | 12:00 - 1:30 p.m. ET
A Virtual Discussion Moderated by CNBC's Meg Tirrell
The resurgence of SARS-CoV-2 infections that is occurring as many people around the world emerge from a period of virtual exile that was designed to curb the spread of the virus underlines the resilience of humanity’s elusive new enemy. As we continue to keep our distance and wear face masks in public, numerous factors complicate our efforts to keep COVID-19 at bay. Among them are the unpredictable nature of the disease, which produces no symptoms in some patients while causing severe illness or death in others, and the challenges associated with testing large portions of the human population in order to guide people safely back to work.
It is in this context that the Personalized Medicine Coalition has organized COVID-19 and Personalized Medicine: Current Status and Lessons Learned.
Moderated by Meg Tirrell, Reporter, CNBC, and featuring an interview with keynote speaker Scott Gottlieb, M.D., Resident Fellow, American Enterprise Institute, this 90-minute virtual seminar will convene senior leaders from the multiple sectors of the health care ecosystem represented on the Personalized Medicine Coalition’s board of directors to examine the current status of our efforts to address the pandemic with reference to the principles of personalized medicine.